By targeting key pathways such as PI3K/Akt/mTOR and HIF-1α, and integrating the role of the microbiome, more effective and personalized treatment strategies can be formulated to address the complex metabolic challenges associated with sepsis. Here, AKT1 is linked to Sepsis.